Trial Outcomes & Findings for Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy (NCT NCT01170754)

NCT ID: NCT01170754

Last Updated: 2017-09-13

Results Overview

The study is a non-inferiority study: The objective is to conclude that the prep quality scores of those receiving Miralax is at most 10% less than for Golytely. Thus the difference in prep scores between Miralax minus Golytely should be greater than - 10%. If this is the case, Miralax would be considered as non-inferior to Golytely. The outcome measure will use the Boston Prep Scale. The BPS is scored 0-9 with 9 being an excellent preparation throughout the colon. From the right colon, transverse colon , and left colon a score of 0-3 is given as follows and the total BPS is the arithmetic sum from each colon segment: 0 = Unprepared colon segment with mucosa not seen due to solid stool. 1. = Portion of mucosa of the colon segment seen, but other areas of the colon segment not well seen. 2. = Minor amount of residual staining, small fragments of stool and/or opaque liquid 3. = clear colon without staining

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

136 participants

Primary outcome timeframe

photographs were taken throughout the colonoscopy and reviewed within 1 month after procedure.

Results posted on

2017-09-13

Participant Flow

Participant milestones

Participant milestones
Measure
PEG-3350 and Gatorade
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Overall Study
STARTED
66
70
Overall Study
COMPLETED
66
70
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Total
n=136 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
60 Participants
n=99 Participants
64 Participants
n=107 Participants
124 Participants
n=206 Participants
Age, Categorical
>=65 years
6 Participants
n=99 Participants
6 Participants
n=107 Participants
12 Participants
n=206 Participants
Age, Continuous
56.3 years
STANDARD_DEVIATION 8.4 • n=99 Participants
56.7 years
STANDARD_DEVIATION 7.0 • n=107 Participants
56.4 years
STANDARD_DEVIATION 7.7 • n=206 Participants
Sex: Female, Male
Female
30 Participants
n=99 Participants
44 Participants
n=107 Participants
74 Participants
n=206 Participants
Sex: Female, Male
Male
36 Participants
n=99 Participants
26 Participants
n=107 Participants
62 Participants
n=206 Participants

PRIMARY outcome

Timeframe: photographs were taken throughout the colonoscopy and reviewed within 1 month after procedure.

Population: Includes all subjects who were enrolled and underwent procedure (Intention-to-treat analysis)

The study is a non-inferiority study: The objective is to conclude that the prep quality scores of those receiving Miralax is at most 10% less than for Golytely. Thus the difference in prep scores between Miralax minus Golytely should be greater than - 10%. If this is the case, Miralax would be considered as non-inferior to Golytely. The outcome measure will use the Boston Prep Scale. The BPS is scored 0-9 with 9 being an excellent preparation throughout the colon. From the right colon, transverse colon , and left colon a score of 0-3 is given as follows and the total BPS is the arithmetic sum from each colon segment: 0 = Unprepared colon segment with mucosa not seen due to solid stool. 1. = Portion of mucosa of the colon segment seen, but other areas of the colon segment not well seen. 2. = Minor amount of residual staining, small fragments of stool and/or opaque liquid 3. = clear colon without staining

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Boston Prep Scale
7.0 units on a scale
Standard Deviation 2.1
7.2 units on a scale
Standard Deviation 1.9

SECONDARY outcome

Timeframe: Day of procedure

Sodium level: Risks from the preparation include failure to cleanse the colon adequately and the risk of electrolyte abnormalities, particularly hypokalemia. We will compare adverse events from the comparator preps by assessing electrolytes on the day of the procedure.

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Sodium Level in mmol/L
138.8 mmol/L
Standard Deviation 2.4
139.3 mmol/L
Standard Deviation 2.4

SECONDARY outcome

Timeframe: Day of procedure

Potassium level: Risks from the preparation include failure to cleanse the colon adequately and the risk of electrolyte abnormalities, particularly hypokalemia. We will compare adverse events from the comparator preps by assessing electrolytes on the day of the procedure.

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Potassium Level in mmol/L
4.0 mmol/L
Standard Deviation 3.2
3.9 mmol/L
Standard Deviation 3.5

SECONDARY outcome

Timeframe: Day of procedure

Chloride level: Risks from the preparation include failure to cleanse the colon adequately and the risk of electrolyte abnormalities, particularly hypokalemia. We will compare adverse events from the comparator preps by assessing electrolytes on the day of the procedure.

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Chloride Level in mmol/L
104.1 mmol/L
Standard Deviation 2.6
104.2 mmol/L
Standard Deviation 3.2

SECONDARY outcome

Timeframe: Day of procedure

Bicarbonate level: Risks from the preparation include failure to cleanse the colon adequately and the risk of electrolyte abnormalities, particularly hypokalemia. We will compare adverse events from the comparator preps by assessing electrolytes on the day of the procedure.

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Bicarbonate Level in mmol/L
26.4 mmol/L
Standard Deviation 2.5
25.9 mmol/L
Standard Deviation 2.5

SECONDARY outcome

Timeframe: Day of procedure

BUN level: Risks from the preparation include failure to cleanse the colon adequately and the risk of electrolyte abnormalities, particularly hypokalemia. We will compare adverse events from the comparator preps by assessing electrolytes on the day of the procedure.

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
BUN Level in mg/dl
9.0 mg/dl
Standard Deviation 3.4
9.5 mg/dl
Standard Deviation 4.0

SECONDARY outcome

Timeframe: Day of procedure

Creatinine level: Risks from the preparation include failure to cleanse the colon adequately and the risk of electrolyte abnormalities, particularly hypokalemia. We will compare adverse events from the comparator preps by assessing electrolytes on the day of the procedure.

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Creatinine Level in mg/dl
0.9 mg/dl
Standard Deviation 0.19
1.1 mg/dl
Standard Deviation 2.0

SECONDARY outcome

Timeframe: Day of procedure

Glucose level: Risks from the preparation include failure to cleanse the colon adequately and the risk of electrolyte abnormalities, particularly hypokalemia. We will compare adverse events from the comparator preps by assessing electrolytes on the day of the procedure.

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Glucose Level in mg/dl
98.2 mg/dl
Standard Deviation 12.2
93.7 mg/dl
Standard Deviation 21.5

SECONDARY outcome

Timeframe: Day of procedure

Calcium level: Risks from the preparation include failure to cleanse the colon adequately and the risk of electrolyte abnormalities, particularly hypokalemia. We will compare adverse events from the comparator preps by assessing electrolytes on the day of the procedure.

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Calcium Level in mg/dl
9.3 mg/dl
Standard Deviation 0.35
9.3 mg/dl
Standard Deviation 0.46

SECONDARY outcome

Timeframe: Day of procedure

Magnesium level: Risks from the preparation include failure to cleanse the colon adequately and the risk of electrolyte abnormalities, particularly hypokalemia. We will compare adverse events from the comparator preps by assessing electrolytes on the day of the procedure.

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Magnesium Level in mg/dl
2.1 mg/dl
Standard Deviation 0.20
2.1 mg/dl
Standard Deviation 0.26

SECONDARY outcome

Timeframe: Day of procedure

Phosphorus level: Risks from the preparation include failure to cleanse the colon adequately and the risk of electrolyte abnormalities, particularly hypokalemia. We will compare adverse events from the comparator preps by assessing electrolytes on the day of the procedure.

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=66 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Phosphorus Level in mg/dl
3.4 mg/dl
Standard Deviation 0.52
3.5 mg/dl
Standard Deviation 0.60

OTHER_PRE_SPECIFIED outcome

Timeframe: photographs were taken throughout colonoscopy and reviewed within 1 month after procedure

Population: Includes subjects who followed instructions (Per Protocol analysis)

Analysis includes a sub-group of subjects who drank \>75% of the preparation and adhered to a clear liquid diet (Per Protocol). The BPS is scored 0-9 with 9 being an excellent preparation throughout the colon. From the right colon, transverse colon , and left colon a score of 0-3 is given as follows and the total BPS is the arithmetic sum from each colon segment:

Outcome measures

Outcome measures
Measure
PEG-3350 and Gatorade
n=50 Participants
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=54 Participants
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Boston Prep Scale (Per Protocol Analysis)
7.4 units on a scale
Standard Deviation 1.8
7.4 units on a scale
Standard Deviation 1.7

Adverse Events

PEG-3350 and Gatorade

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Golytely 4 Liters

Serious events: 0 serious events
Other events: 4 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
PEG-3350 and Gatorade
n=66 participants at risk
255 miralax with 64 oz gatorade. Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Golytely 4 Liters
n=70 participants at risk
Golytely 4 Liters Golytely vs. Miralax plus gatorade: 4L of golytely vs. 255 grams of PEG-3350 mixed with 64 ounces gatorade for colonoscopy preparation.
Renal and urinary disorders
Hypokalemia
6.1%
4/66 • Number of events 4 • Only for the day of the procedure for electrolytes and 24 hours later for symptoms after procedure and complications from colonoscopy.
We checked a basic metabolic profile on day of colonoscopy. All patients called the day after procedure to assess for complications.
5.7%
4/70 • Number of events 4 • Only for the day of the procedure for electrolytes and 24 hours later for symptoms after procedure and complications from colonoscopy.
We checked a basic metabolic profile on day of colonoscopy. All patients called the day after procedure to assess for complications.

Additional Information

Frank Friedenberg, MD

Temple University

Phone: 215-707-9900

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place